Can bismuth decrease the kidney toxic effect of cis-platinum?
Sommer
S
S
Danish Cancer Society, Section of Clinical Research, Aarhus.
Thorling
E B
EB
Jakobsen
A
A
Steiness
E
E
Ostergaard
K
K
D001729:Bismuth / Q000627:therapeutic use*; D002945:Cisplatin / Q000009:adverse effects*; D005260:Female; D006801:Humans; D007674:Kidney Diseases / Q000139:chemically induced / Q000517:prevention & control*; D009942:Organometallic Compounds / Q000627:therapeutic use*; D010051:Ovarian Neoplasms / Q000188:drug therapy; D012459:Salicylates / Q000627:therapeutic use*
D009942:Organometallic Compounds; D012459:Salicylates; C015715:bismuth subsalicylate; D002945:Cisplatin; D001729:Bismuth